Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases

PURPOSE: The aim of this study was to compare disease-free survival (DFS) and overall survival (OS) between clinically node-positive breast cancer patients, treated with neoadjuvant chemotherapy (NAC), with axillary pathologic complete response (ypN0), residual axillary isolated tumor cells or micro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: van Nijnatten, T. J. A., Simons, J. M., Moossdorff, M., de Munck, L., Lobbes, M. B. I., van der Pol, C. C., Koppert, L. B., Luiten, E. J. T., Smidt, M. L.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2017
Assuntos:
Epidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5387009/
https://ncbi.nlm.nih.gov/pubmed/28213782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-017-4157-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados